⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLYM News
Climb Bio, Inc. Common Stock
Climb Bio Reports Second Quarter 2026 Financial Results and Provides Business Updates
globenewswire.com
CLYM
Form 8-K
sec.gov
CLYM
Form 8-K
sec.gov
CLYM
Form 8-K
sec.gov
CLYM
Climb Bio Announces Initial Phase 1b Data Demonstrating On-Target Clinical Activity for Budoprutug in Immune Thrombocytopenia at EHA Congress 2026
globenewswire.com
CLYM
Form 8-K
sec.gov
CLYM
Form 8-K
sec.gov
CLYM
Climb Bio Presents CLYM116 Initial Phase 1 Safety Data and Translational Modeling Results at European Renal Association (ERA) Congress 2026 Supporting Continued Development
globenewswire.com
CLYM
Climb Bio to Present on CLYM116 and Budoprutug Programs at European Renal Association (ERA) Congress 2026
globenewswire.com
CLYM
Climb Bio to Present New Budoprutug Clinical Data at European Hematology Association (EHA) 2026 Congress
globenewswire.com
CLYM